Did you miss AMA’s 2010 Interim Meeting of the House of Delegates? Don’t worry, The Doctor’s Channel has you covered. Get all of the highlights from the meeting…
NEW YORK (Reuters Health) – Compared with zoledronic acid, the monoclonal antibody denosumab is more effective in delaying skeletal-related events in women with breast cancer that has metastasized…
NEW YORK (Reuters Health) – White matter (WM) hyperintensities seen on MRI brain scans correlate with gait and stability difficulties in elderly subjects, as well as with reduced…
NEW YORK (Reuters Health) – Patients who begin dialysis when kidney disease is at a relatively early stage have an increased risk of dying in the following year,…
The Doctor’s Channel is on location in Chicago at the American Heart Association Scientific Sessions 2010. We will be bringing you need-to-know information on late breaking trials, scientific…
NEW YORK (Reuters Health) – The school performance at age 16 of children born to epileptic mothers correlates with their degree of exposure to anticonvulsant drugs in utero,…
NEW YORK (Reuters Health) – Updated guidelines compiled by an expert panel of cardiologists and gastroenterologists address the issue of a possible drug interaction between proton pump inhibitors…
NEW YORK (Reuters Health) – About one in seven children with a first urinary tract infection have evidence of renal scarring subsequently, a meta-analysis of published studies shows.…
NEW YORK (Reuters Health) – Benign or malignant breast lesions can be differentiated noninvasively by overlaying 3-D digital mammography images with tissue-physiology images obtained by scanning with near…
NEW YORK (Reuters Health) – Forget those headlines from the past few years linking hypercholesterolemia in midlife to risk of dementia in old age. Data presented in the…
NEW YORK (Reuters Health) – Short-term testosterone treatment in frail elderly men improves muscle mass and strength, but the effects don’t last more than 6 months after treatment…
NEW YORK (Reuters Health) – The tyrosine kinase inhibitors gefitinib or erlotinib may slow the development of central nervous system metastases in patients with advanced non-small cell lung…
